ATE542903T1 - Luciferase-biosensoren für camp - Google Patents

Luciferase-biosensoren für camp

Info

Publication number
ATE542903T1
ATE542903T1 AT09750966T AT09750966T ATE542903T1 AT E542903 T1 ATE542903 T1 AT E542903T1 AT 09750966 T AT09750966 T AT 09750966T AT 09750966 T AT09750966 T AT 09750966T AT E542903 T1 ATE542903 T1 AT E542903T1
Authority
AT
Austria
Prior art keywords
camp
luciferase biosensors
biosensors
luciferase
luciferase protein
Prior art date
Application number
AT09750966T
Other languages
English (en)
Inventor
Lance Encell
Kris Zimmerman
Paul Otto
Gediminas Vidugiris
Pete Stecha
Brock Binkowski
Monika Wood
Keith Wood
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of ATE542903T1 publication Critical patent/ATE542903T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD or ATP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT09750966T 2008-05-19 2009-05-19 Luciferase-biosensoren für camp ATE542903T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5437408P 2008-05-19 2008-05-19
US11998308P 2008-12-04 2008-12-04
PCT/US2009/003132 WO2009142735A2 (en) 2008-05-19 2009-05-19 LUCIFERASE BIOSENSORS FOR cAMP

Publications (1)

Publication Number Publication Date
ATE542903T1 true ATE542903T1 (de) 2012-02-15

Family

ID=41202867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09750966T ATE542903T1 (de) 2008-05-19 2009-05-19 Luciferase-biosensoren für camp

Country Status (5)

Country Link
US (2) US9045730B2 (de)
EP (1) EP2281046B1 (de)
JP (2) JP6110591B2 (de)
AT (1) ATE542903T1 (de)
WO (1) WO2009142735A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005038029A2 (en) 2003-10-10 2005-04-28 Promega Corporation Luciferase biosensor
US9359635B2 (en) * 2006-04-03 2016-06-07 Promega Corporation Permuted and nonpermuted luciferase biosensors
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
ES2795287T3 (es) * 2009-05-01 2020-11-23 Promega Corp Luciferasas de Oplophorus sintéticas con mayor emisión de luz
EP2990479B1 (de) 2010-05-11 2019-03-27 Promega Corporation Mutante protease-biosensoren mit verbesserten erkennungseigenschaften
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
CA2815381C (en) 2010-11-02 2019-03-19 Promega Corporation Coelenterazine derivatives and methods of using same
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
AU2011335901B2 (en) 2010-12-03 2016-12-15 Gene Stream Pty Ltd Improved light-emitting molecules
WO2013138684A1 (en) 2012-03-15 2013-09-19 Montana Molecular Llc Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways
JP2015000021A (ja) * 2013-06-14 2015-01-05 浜松ホトニクス株式会社 細胞内cAMP濃度を制御する方法
JP6484987B2 (ja) 2013-10-21 2019-03-20 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
EP3738971B1 (de) 2013-11-04 2024-07-17 Montana Molecular LLC Genetisch codierte fluoreszenzsensoren zur erkennung von liganden-bias und intrazellulärer signalisierung durch camp-signalwege
EP3099691B1 (de) 2014-01-29 2019-11-20 Promega Corporation Pro-substrate für lebendzellanwendungen
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
JP6265020B2 (ja) * 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
US10316070B2 (en) 2016-09-09 2019-06-11 Promega Corporation Dual protected pro-coelenterazine substrates
WO2020050208A1 (ja) * 2018-09-05 2020-03-12 ヤマサ醤油株式会社 Tsh受容体に対する自己抗体活性の迅速測定方法及びキット
KR102982241B1 (ko) * 2019-03-12 2026-06-25 오르토-클리니칼 다이아그노스틱스, 인코포레이티드 자가항체 검출용 조성물, 키트, 및 방법
US20210318292A1 (en) * 2020-04-13 2021-10-14 Sensorium Bio, Inc. System and Method to Detect Small Molecules
EP4519290A1 (de) 2022-05-04 2025-03-12 Promega Corporation Zirkular permutierte dehalogenasevarianten
JP2025516354A (ja) 2022-05-04 2025-05-27 プロメガ コーポレイション スプリット修飾デハロゲナーゼバリアント
WO2025100444A1 (ja) * 2023-11-07 2025-05-15 株式会社コスミックコーポレーション Tsh活性測定用のレポーター細胞

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO864301L (no) 1986-10-28 1988-04-29 Tore Jahnsen Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
WO1990005745A1 (en) 1988-11-18 1990-05-31 The General Hospital Corporation A cAMP-RESPONSIVE TRANSCRIPTIONAL ENHANCER BINDING PROTEIN
US5683888A (en) 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
GB8916806D0 (en) 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
FR2682122B1 (fr) 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
ES2301160T3 (es) 1994-01-03 2008-06-16 Promega Corporation Luciferasas mutantes.
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US6294330B1 (en) 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
US7312302B2 (en) 1997-02-20 2007-12-25 Oncolmmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
EP2860252A1 (de) 1997-09-19 2015-04-15 Promega Corporation Thermostabile Luciferasen und Verfahren zur Herstellung
US6342611B1 (en) 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US6855515B1 (en) 1998-04-22 2005-02-15 Merck & Co., Inc. Autoantigenic fragments, methods and assays
GB9819666D0 (en) 1998-09-09 1998-11-04 Univ Aberdeen Biosensor
US20020192719A1 (en) 1998-09-30 2002-12-19 Caliper Technologies Corp. Homogeneous assay methods
AU1223200A (en) 1998-10-23 2000-05-15 Massachusetts Institute Of Technology Genes integrating signal transduction pathways
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
US6670144B1 (en) 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
JP3059435B1 (ja) 1999-03-18 2000-07-04 扶桑薬品工業株式会社 cAMPおよびアデニル酸シクラ―ゼの酵素的蛍光定量アッセイ
US6573059B1 (en) 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
US7109315B2 (en) 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6808874B2 (en) 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
US6890745B1 (en) 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
JP3772193B2 (ja) 2000-07-26 2006-05-10 独立行政法人科学技術振興機構 蛋白質−蛋白質相互作用解析用プローブ及びそれを利用した蛋白質−蛋白質相互作用の解析方法
US6541196B2 (en) 2000-07-26 2003-04-01 Jackson State University Method for cAMP production
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
US7083911B2 (en) 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
US20030053995A1 (en) 2001-06-15 2003-03-20 Mien-Chie Hung Methods and compositions for inhibiting EGF receptor activity
AU2002364124A1 (en) 2001-11-28 2003-06-10 The Burnham Institute Methods for identifying modulators of apoptosis
US7927871B2 (en) 2002-01-29 2011-04-19 Oncoimmunin, Inc. Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
US7527942B2 (en) 2002-02-08 2009-05-05 The Regents Of The University Of California Transcription amplification system for molecular imaging
US20030170850A1 (en) 2002-03-09 2003-09-11 Cardone Michael H. Cell-based screening methods
US6730492B2 (en) 2002-03-09 2004-05-04 Merrimack Pharmaceuticals, Inc. Cell-based screening methods
ATE487797T1 (de) 2002-09-06 2010-11-15 Promega Corp Verfahren zum nachweis von transferase- enzymaktivität
GB0221915D0 (en) 2002-09-20 2002-10-30 Skeland Stein O D Assay
WO2004038039A2 (en) 2002-10-21 2004-05-06 The Regents Of The University Of California Optical imagiong of renilla luciferase reporter gene expression in living organisms
AU2003287635A1 (en) 2002-11-08 2004-06-03 Sanjiv Sam Gambhir Imaging protein-protein interactions in living subjects
WO2004059294A2 (en) 2002-12-23 2004-07-15 Promega Corporation Improved luciferase-based assays
US7524674B2 (en) 2003-03-07 2009-04-28 Stanford University Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
WO2005015161A2 (en) 2003-08-06 2005-02-17 Washington University In St. Louis Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
US7488583B2 (en) 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
WO2005038029A2 (en) 2003-10-10 2005-04-28 Promega Corporation Luciferase biosensor
EP1536020A1 (de) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Mittel und Verfahren zur optischen Bestimmung von cAMP in vitro und in vivo
US20060110364A1 (en) 2004-08-20 2006-05-25 Ludwig Institute For Cancer Research Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors
EP1791972A4 (de) 2004-08-23 2009-12-02 Univ Johns Hopkins cAMP-REPORTER
US20060048592A1 (en) 2004-09-09 2006-03-09 Ung Tom T Damping nut for screw-driven mechanism
AU2006281994B2 (en) 2005-08-19 2011-10-06 Commonwealth Scientific And Industrial Research Organisation Arachnocampa luciferases
US9359635B2 (en) 2006-04-03 2016-06-07 Promega Corporation Permuted and nonpermuted luciferase biosensors
CN101578373A (zh) 2006-09-06 2009-11-11 费斯生物制药公司 融合肽治疗组合物
US7812002B2 (en) 2007-03-21 2010-10-12 Quark Pharmaceuticals, Inc. Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
EP2154159A4 (de) 2007-05-09 2012-03-21 Univ Tokyo Indikator für aktivierte protease
WO2009049892A1 (en) 2007-10-17 2009-04-23 European Molecular Biology Laboratory (Embl) Polypeptides comprising an annexin core domain, compositions, methods and use thereof
CN101849005A (zh) 2007-11-05 2010-09-29 普罗梅加公司 杂合融合报道子及其应用
WO2009140662A1 (en) 2008-05-15 2009-11-19 Illumina, Inc. Engineered luciferases
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
EP2990479B1 (de) 2010-05-11 2019-03-27 Promega Corporation Mutante protease-biosensoren mit verbesserten erkennungseigenschaften
JP5501862B2 (ja) 2010-05-24 2014-05-28 株式会社サンユー 金属被膜見本キット
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
EP2776573A1 (de) 2011-11-11 2014-09-17 Promega Corporation Mutante protease-biosensoren mit verbesserten erkennungseigenschaften

Also Published As

Publication number Publication date
JP2015091253A (ja) 2015-05-14
EP2281046A2 (de) 2011-02-09
WO2009142735A3 (en) 2010-01-14
EP2281046B1 (de) 2012-01-25
JP6110591B2 (ja) 2017-04-05
US9045730B2 (en) 2015-06-02
WO2009142735A2 (en) 2009-11-26
US20150299765A1 (en) 2015-10-22
US20090305280A1 (en) 2009-12-10
US9879306B2 (en) 2018-01-30
JP6275635B2 (ja) 2018-02-07
JP2011520466A (ja) 2011-07-21

Similar Documents

Publication Publication Date Title
WO2009142735A3 (en) LUCIFERASE BIOSENSORS FOR cAMP
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
DE112007001307A5 (de) Mikrobiologische Herstellung von 3-Hydroxyisobuttersäure
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2344632A4 (de) Verfahren zur herbeiführung von pluripotenzen in zellen
EP2297182A4 (de) Supergeladene proteine zur zellpenetration
BRPI0918648A2 (pt) anticorpos multiespecíficos
BRPI0921243A2 (pt) fornecimento de história recente com resultados de pesquisa.
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
BRPI0919186A2 (pt) aparelhos de barbear ou depilar e cartuchos.
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
MA32712B1 (fr) Anticorps anti-vegf/anti-ang-2 bispecifique
EA201000327A1 (ru) Белок
EP2300005A4 (de) Kleinmolekulare inhibitoren von botulinus-neurotoxinen
EP2518158A4 (de) Marker für pankreaskarzinom, nachweisverfahren, kits und biochips dafür
DK2002016T3 (da) Fremgangsmåde til bestemmelse af kopital
EP2274416A4 (de) Kommensale bakterien als signalvermittler in einem säugerwirt
EP2516624A4 (de) Zelllinie 3m
BRPI0914098A2 (pt) biosensor
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
EP2280284A4 (de) Biosensor
DK2179035T3 (da) Modificeret bakteriofag omfattende et alfa/beta-sasp-(small acid-soluble spore protein)-gen
DOP2009000088A (es) Pirazoles sustituidos que presentan actividad anticancerígena
BR112014014279A2 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit